Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
FDA Dayvigo (lemborexant) Insomnia
.
Show all posts
Showing posts with label
FDA Dayvigo (lemborexant) Insomnia
.
Show all posts
Monday, February 17, 2020
FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients
›
In continuation of my update on lemborexant Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that...
›
Home
View web version
